龙口联合化学股份有限公司 2024年年度权益分派实施公告 证券代码：301209 证券简称：联合化学 公告编号：2025-025 公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 1 公司2024年年度权益分派方案为：以公司现有总股本80,000,000股为基数， 向全体股东每10股派2.00元人民币现金（含税；扣税后，"境外机构（QFII、RQFII）" 以及持有首发前限售股的个人和证券投资基金每10股派1.80元；持有首发后限售 股、股权激励限售股及无限售流通股的个人股息红利税实行差别化税率征收，公 司暂不扣缴个人所得税，待个人转让股票时，根据其持股期限计算应纳税额【注】； 持有首发后限售股、股权激励限售股及无限售流通股的证券投资基金所涉红利税， 对香港投资者持有基金份额部分按10%征收，对内地投资者持有基金份额部分实 行差别化税率征收），同时以资本公积金向全体股东每10股转增4股。 龙口联合化学股份有限公司（以下简称"公司"）《关于公司2024年度利润分 配及资本公积转增股本方案的议案》已获2025年5月19日召开的2024年年度股东 大会审议通过，现将权 ...

Core Viewpoint - The company, United Chemical, has announced significant stock price fluctuations and potential risks associated with its new joint venture, Qichen Semiconductor, which is still in the early stages of development and market entry [2][3]. Group 1: Stock Performance - As of May 23, United Chemical's stock price increased by 15.22%, closing at 124.15 yuan, marking a historical high [2]. - Over the past year, the company's stock price has surged by 394.82%, while the CSI 300 index has only risen by 6.60% during the same period [2]. - The stock has shown a significant deviation in price, with a 202.59% deviation over 27 consecutive trading days, indicating severe abnormal trading fluctuations [2]. Group 2: Valuation Comparison - The company's rolling price-to-earnings (P/E) ratio stands at 176.00, which is significantly higher than the industry average P/E ratio of 23.28 for the chemical raw materials and products manufacturing sector [3]. - This discrepancy raises concerns about the stock's valuation relative to its peers, prompting the company to advise investors to be cautious in their trading decisions [3]. Group 3: Joint Venture and Market Strategy - United Chemical has established a joint venture, Qichen Semiconductor, in collaboration with Shanghai Panwo Fine Chemical Co., Ltd. and Beijing Shanggu Lianheng Chemical Technology Co., Ltd., focusing on the development and production of various semiconductor-related chemicals [3][4]. - The company aims to leverage its experience in fine chemical synthesis and surface treatment to enter the electronic chemicals market, which is characterized by high technical barriers and significant profit margins [4]. - The initial production capacity for the project is designed to be 200 tons per year, with plans for increased R&D investment and technical personnel to enhance capabilities [4]. Group 4: Financial Performance - For the year 2024, United Chemical projects a revenue of 53,461.73 million yuan, reflecting a year-on-year growth of 24.8%, and a net profit attributable to shareholders of 5,643.21 million yuan, up 66.81% [4]. - In the first quarter of 2025, the company reported a revenue of 13,006.19 million yuan, a slight increase of 0.52%, but the net profit decreased by 17.97% to 1,654.22 million yuan [4].

重要内容提示： 1、股价短期上涨风险。根据《深圳证券交易所交易规则》的有关规定，公 司股票连续27个交易日收盘价格涨幅偏离值达202.59%，属于股票交易严重异常 波动情形。 公司股票价格短期大幅上涨，可能存在短期涨幅较大回落的风险。公司郑重 提醒广大投资者，注意二级市场交易风险，审慎决策、理性投资。 2、股价偏离同行业上市公司估值。截至2025年5月23日，公司的滚动市盈率 为176.00。根据中证指数有限公司最新数据显示，公司所属中上协行业分类制造 业-化学原料和化学制品制造业（C26）的滚动市盈率为23.28,公司最新市盈率与 同行业相比有较大差异。敬请广大投资者理性投资。 3 、 基 本 面 未 发 生 重 大 变 化 。 公 司 于 2025 年 4月 28 日 在 巨 潮 资讯 网 （www.cninfo.com.cn）披露了《2024年年度报告》（公告编号：2025-006），公 司2024年度实现营业收入53,461.73万元，同比增长24.80%；归属于公司股东的净 利润5,643.21万元，同比增长66.81%。公司于2025年4月28日在巨潮资讯网 （www.cninfo.com.cn） ...

Company Announcements - Weir Shares plans to issue H-shares and list on the Hong Kong Stock Exchange to accelerate international strategy and enhance overseas financing capabilities [1] - Zhongjin Gold's controlling shareholder plans to inject four companies, including Inner Mongolia Jintao, into the company to resolve competition issues [2] - Hanchuan Intelligent has filed a lawsuit against CATL and its subsidiaries for approximately 60.88 million yuan due to payment defaults [2] - Yunnan Copper intends to acquire a 40% stake in Liangshan Mining, with stock resuming trading on May 26 [3] - China Shenhua plans to acquire a 7.43% stake in China Energy Group Financial Company for 2.929 billion yuan [3] - Dike Co. intends to acquire 60% of Zhejiang Suote for 696 million yuan to control the Solamet photovoltaic silver paste business [4] - Jin Hua Co.'s chairman is under investigation for information disclosure violations, but it will not affect the company's operations [4] Financing and Investments - Heng Rui Pharmaceutical's H-shares will be listed on May 23, 2025, with a total issuance of 225 million shares at a price of 44.05 HKD per share [23] - Ningde Times' investment fund has increased to 10.128 billion yuan, with the company's stake reduced to 6.91% [8] - Intercontinental Oil and Gas expects to invest approximately 848 million USD in the Iraq South Basra project [9] - Keli Yuan plans to invest an additional 500 million yuan in a storage industry fund, increasing its total investment to 700 million yuan [10] Project Bids and Contracts - China Communications has won important rail transit projects totaling approximately 3.789 billion yuan [22] - Anhui Construction has received multiple project bids totaling over 2 billion yuan [22] Operational Updates - Zijin Mining's Kamoa-Kakula copper mine has suspended some underground mining operations due to seismic activity, potentially impacting future production [21] - Shaanxi Natural Gas will reduce pipeline transportation prices by 0.0386 yuan per cubic meter, expected to decrease net profit by approximately 222 million yuan in 2025 [20]

Core Viewpoint - The stock of Longkou United Chemical Co., Ltd. has experienced significant volatility, with a 202.59% increase in closing price over 27 consecutive trading days, indicating severe abnormal trading behavior [1][2] Financial Performance - For the fiscal year 2024, the company reported a revenue of 534.62 million yuan, representing a year-on-year growth of 24.80%, and a net profit attributable to shareholders of 56.43 million yuan, which is an increase of 66.81% [1] - In the first quarter of 2025, the company achieved a revenue of 130.06 million yuan, showing a slight year-on-year increase of 0.52%, while the net profit attributable to shareholders was 16.54 million yuan, reflecting a decrease of 17.97% compared to the previous year [2] Stock Trading Behavior - The company has issued a warning regarding the potential risks associated with the recent sharp increase in stock price, advising investors to be cautious and make rational investment decisions [1][2] - The company confirmed that there are no undisclosed significant matters that could impact stock trading prices, and all previously disclosed information remains accurate [2] Business Operations - The company specializes in the research, production, and sales of azo organic pigments and water-based inks, with its main products being yellow, red, and orange azo organic pigments [3] - The establishment of a joint venture, Qichen Semiconductor, has been completed, although the project is still in its early stages and may face uncertainties regarding production and market development [3]

联合化学：启辰半导体产线调试、产能释放、生产基地验证仍需一段时间 智通财经5月23日电，联合化学(301209.SZ)发布风险提示公告，目前合资公司启辰半导体初步设立，从 项目试生产至规模化量产，产线调试、产能释放、生产基地验证仍需一段时间，客户开拓也需要一定时 间，未来的市场变化等尚存在不确定性，可能导致项目进度及产生效益不及预期的风险。 ...

联合化学（301209）发布股价短期上涨风险提示，根据《深圳证券交易所交易规则》相关规定，公司股 票连续27个交易日收盘价格涨幅偏离值达202.59%，属于股票交易严重异常波动情形。公司股票价格短 期大幅上涨，可能存在短期涨幅较大回落的风险。公司郑重提醒广大投资者，注意二级市场交易风险， 审慎决策、理性投资。 ...

证券代码：301209 证券简称：联合化学 公告编号：2025-024 龙口联合化学股份有限公司 1、股价短期上涨风险。根据《深圳证券交易所交易规则》的有关规定，公 司股票连续27个交易日收盘价格涨幅偏离值达202.59%，属于股票交易严重异常 波动情形。 公司股票价格短期大幅上涨，可能存在短期涨幅较大回落的风险。公司郑 重提醒广大投资者，注意二级市场交易风险，审慎决策、理性投资。 2、股价偏离同行业上市公司估值。截至2025年5月23日，公司的滚动市盈率 为176.00。根据中证指数有限公司最新数据显示，公司所属中上协行业分类制 造业-化学原料和化学制品制造业（C26）的滚动市盈率为23.28,公司最新市盈率 与同行业相比有较大差异。敬请广大投资者理性投资。 3 、 基 本 面 未 发 生 重 大 变 化 。 公司于 2025 年 4 月 28 日 在 巨 潮资 讯 网 （www.cninfo.com.cn）披露了《2024年年度报告》（公告编号：2025-006），公 司2024年度实现营业收入53,461.73万元，同比增长24.80%；归属于公司股东的 净利润5,643.21万元，同比增长66.81% ...

Market Overview - A-shares maintained a volatile trend with major indices supported by sectors such as pharmaceuticals, chemicals, and automobiles. The Shenzhen index outperformed the Shanghai index, with the Shanghai Composite Index up 0.08%, Shenzhen Component Index up 0.50%, and ChiNext Index up 0.48% at midday [1] - Hong Kong stocks also saw gains, with the Hang Seng Index up 0.58% and the Hang Seng Tech Index up 0.61% at midday [1] Pharmaceutical Sector - The pharmaceutical sector experienced a surge following the strong debut of Hengrui Medicine on the Hong Kong stock market. Stocks such as Duorui Medicine and Haichen Pharmaceutical hit the 20% limit up, while several others rose over 10% [2][4] - Hengrui Medicine's IPO was priced at HKD 44.05 per share, raising approximately HKD 9.9 billion, marking the largest IPO in the Hong Kong pharmaceutical sector in the past five years. The company plans to allocate about 75% of the funds for R&D, 15% for building new facilities, and 10% for working capital [4] - The aging population is driving demand for healthcare, creating a favorable environment for pharmaceutical investments. The market for consumer healthcare products is expected to grow as the elderly population increases [4][5] Chemical Sector - The chemical sector has been active, with several stocks showing significant gains. Companies like United Chemical and Yanggu Huatai saw increases of over 12% [6] - United Chemical has seen its stock price increase over tenfold, focusing on organic pigments and electronic chemicals, which are in high demand due to their applications in high-tech industries [8] Automotive Sector - The automotive sector showed strong performance, with stocks like Demais hitting the 20% limit up and BYD rising over 4%, reaching a new historical high [9][14] - In May, the retail market for narrow passenger vehicles is estimated to be around 1.85 million units, a year-on-year increase of 8.5%. The penetration rate for new energy vehicles reached approximately 52.9% [13]

在医药、化工、汽车等多个板块提振下，A股市场主要股指今日维持震荡走势，深市股指表现强于沪市股指。 截至午间收盘，上证指数涨0.08%，深证成指涨0.50%，创业板指涨0.48%。 港股今日震荡走高，截至午间收盘，恒生指数涨0.58%，恒生科技指数涨0.61%。值得一提的是，在恒瑞医药上市大涨带动下，港股医药股普遍走高，昭衍新药、泰 格医药、绿叶制药等涨幅居前。 医药板块爆发 在恒瑞医药港股上市首日大涨的刺激下，A股医药板块爆发。截至午间收盘，多瑞医药20%涨停，海辰药业一度20%涨停，新天地、科源制药等上涨超10%，众生药 业、贝瑞基因、海森药业等多股涨停。 | 序号代码 | | 名称 | 现价 | 涨跌 | 涨跌幅, | | | --- | --- | --- | --- | --- | --- | --- | | 1 | 301075 | 多瑞医药 | 28.92 | 4.82 | 20.00% | | | 2 | 300584 | 海辰药川 | 35.13 | 5.83 | 19.90% | | | 3 | 301277 | 新天地 | 15.05 | 2.31 | 18.13% | | | ব | 3 ...